Special Issue "Use of Antibodies/Antivenom Against Envenoming"
Deadline for manuscript submissions: 15 April 2017
Antivenoms remain the mainstay treatment of systemic envenoming in humans following bites by a range of animals. However, there is still considerable debate about the effectiveness of some antivenoms, the correct dose and frequency of administration of antivenoms to maximise their effectiveness, as well as the ability of antivenoms to cross-neutralise the effects of venom from closely related, or even unrelated, species. There is also a lack of clarity regarding the ability of antivenoms to neutralise different classes of toxins and the timeframe for this neutralisation to occur. This Special Issue of Toxins aims to provide insight into these issues as well as provide the opportunity for exploration of emerging issues in the use and/or development of antivenoms.
Prof. Dr. Wayne Hodgson
Prof. Dr. Geoff Isbister
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed Open Access monthly journal published by MDPI.
- cross neutralization